Responsable(s)
Directrice - Chantal BOULANGER à partir du 01/01/2019 ( chantal.boulanger@inserm.fr )
|
|
Etablissements. |
|
INSERM - Institut national de la sante et de la recherche medicale (U 970)
(établissement tutelle à
partir de 2010)
|
|
U PARIS Cité - Université Paris Cité (UMR_S 970)
(établissement tutelle à
partir de 2020)
Etablissement référent
|
|
CNRS - Centre national de la recherche scientifique (U 970)
(établissement participant à
partir de 2010)
|
|
AP-HP - Assistance Publique des Hôpitaux de Paris (U 970)
(établissement participant à
partir de 2010)
|
Adresse
HOPITAL EUROPEEN GEORGES POMPIDOU, 56 RUE LEBLANC
75015 PARIS
|
Contact
courriel : parcc.u970@inserm.fr
|
| Site web :
http://parcc.inserm.fr/
|
| Taille en ETP (sans compter les stagiaires):
supérieure à 50.
|
Descriptif :
The PARCC is dedicated to experimental disease-oriented research and has as primary aim to catalyze and speed up the production of basic knowledge related to the understanding of the cellular and molecular basis of cardiovascular disease. Its main mission is to maintain an optimal scientific and medical environment in order to promote excellence in cardiovascular translational research.
Our overall goals for the 2019-23 period are :
1. to pursue internationally leading laboratory-to-bedside research programs that address fundamental molecular, cellular and physiological mechanisms underlying normal and abnormal cardiovascular function and diseases ;
2. to maintain a highly collaborative, multi-disciplinary environment which catalyzes the pursuit of imaginative and innovative research programs, based on complementary expertise of the PARCC teams (cell and molecular biology, physiology/pathophysiology, pharmacology, immunology, endocrinology, genetics, epidemiology, imaging) ;
3. to link these to translational research that improves the prevention, diagnosis and treatment of human cardiovascular disease ;
4. to establish an optimal environment with cutting-edge technology ; 5. to undertake high-quality research training of non-clinical and clinical scientists.
The strategy to achieve our objectives is multifaceted, but is mainly built upon the expertise in basic and clinical translational research of the teams that started internal collaborations, as well as upon strong interactions with the clinical divisions at HEGP (cardiology, cardiovascular prevention, hypertension, medicine, genetics, cardiac and vascular surgery), as well as with the Clinical Investigation Center and the Clinical Research Unit.
|
| Année de création :
2010
|
| Mission de la structure :
Recherche
|
| Mode de gestion de la structure :
Non renseigné.
|
| SIRET de la structure :
Non renseigné.
|
Classement scientifique ERC
- LS4 : Physiology in Health, Disease and Ageing : Organ and tissue physiology, comparative physiology, physiology of ageing, pathophysiology, inter-organ and tissue communication, endocrinology, nutrition, metabolism, interaction with the microbiome, non-communicable diseases including cancer (and except disorders of the nervous system and immunity-related diseases)
|
Domaine scientifique
- 5 : Biologie, médecine et santé 2010 0
|
Ecole(s) doctorale(s) de rattachement
Non renseigné
|
Rattachée au(x) programme(s) LOLF suivant(s):
- prg172-05 : Recherches scientifiques et technologiques en sciences de la vie, biotechnologies et santé
|
Rattachée au(x) thème(s) de recherche suivant(s):
Non renseigné
|
Liens avec d'autres structures :
Aucun.
|
Site ESR :
Aucun.
|
Fiche mise à jour par Alexandre Fabrer le 12/01/2024 à 13:31
|
